BeyondSpring Inc. (BYSI)

2.1300 -0.1400 (-6.17%) At close: 04:00PM EDT

BeyondSpring Inc.

28 Liberty Street
39th Floor
New York, NY 10005
United States
646 305 6387
https://beyondspringpharma.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 73

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Lan Huang Ph.D.	Co-Founder, Chairman & CEO	N/A	N/A	1971
Mr. Linqing Jia	Co-Founder	N/A	N/A	N/A
Dr. June Lu Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Stephen Kilmer	Head of Investor Relations	N/A	N/A	N/A
Mr. Gregg Russo	Senior Vice President of Human Resources	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

Corporate governance

BeyondSpring Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.